Yash Pharma Laboratories Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 9.50 Cr
as on 04-07-2024
- Paid Up Capital ₹ 6.56 Cr
as on 04-07-2024
- Company Age 51 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 94.23 Cr
as on 04-07-2024
- Satisfied Charges ₹ 34.89 Cr
as on 04-07-2024
- Revenue -1.56%
(FY 2023)
- Profit 111.12%
(FY 2023)
- Ebitda -3.56%
(FY 2023)
- Net Worth -1.14%
(FY 2023)
- Total Assets 5.18%
(FY 2023)
About Yash Pharma Laboratories
The Corporate was formerly known as Yash Pharma Laboratories Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.50 Cr and a paid-up capital of Rs 6.56 Cr.
The company currently has active open charges totaling ₹94.23 Cr. The company has closed loans amounting to ₹34.89 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nayana Shah, Yashodhan Shah, and Atri Shah serve as directors at the Company.
- CIN/LLPIN
U24239MH1972PLC300611
- Company No.
300611
- Incorporation Date
18 Nov 1972
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Yash Pharma Laboratories Private Limited offer?
Yash Pharma Laboratories Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Body Lotions, Antibiotic Tablets & Capsules, Azithromycin Tablets, Skin Care Cosmetics, Sunscreen Lotion, Sun Protection Cream, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Common Disease Medicines.
Who are the key members and board of directors at Yash Pharma Laboratories?
Executive Team (1)
YS
Yashodhan Shah
Managing DirectorAppointment Date: 18-Nov-1972
Status: Current
Board Members(2)
Financial Performance and Corporate Structure Insights of Yash Pharma Laboratories.
Yash Pharma Laboratories Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.56% decrease. The company also saw a substantial improvement in profitability, with a 111.12% increase in profit. The company's net worth dipped by a decrease of 1.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yash Pharma Laboratories?
In 2023, Yash Pharma Laboratories had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Bharat Co-Operative Bank(Mumbai) Ltd Creation Date: 07 Nov 2023 | ₹4.00 M | Open |
The Bharat Co-Operative Bank(Mumbai) Ltd Creation Date: 05 Sep 2023 | ₹2.65 M | Open |
Hdfc Bank Limited Creation Date: 24 Aug 2023 | ₹1.23 M | Open |
How Many Employees Work at Yash Pharma Laboratories?
Unlock and access historical data on people associated with Yash Pharma Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
As of Mar 16, 2022, Yash Pharma Laboratories has raised a total of ₹ 3.44 Cr, with the most recent deal valued at ₹ 1.39 Cr. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
